Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Dr. Jerry Vockley, of UPMC Children’s Hospital of Pittsburgh, discusses the limitations of the current treatment options for phenylketonuria...

Barry S. Ticho, MD, PhD, Chief Medical Officer at Stoke Therapeutics, discusses the phase 1/2a MONARCH study, which is evaluating STK-001 in patients with...

Mashup Score:5

CheckRare

Myasthenia Gravis : A History Lesson - 3 days

Mashup Score:5

Dr. Henry Kaminski, of George Washington University, provides a brief history lesson on our understanding of the pathophysiology of myasthenia gravis...

Alok Tayi, PhD, Founder and CEO of Vibe Bio, gives an overview of his company, its mission and objectives, and how it plans to...

Mashup Score:3

CheckRare

PAH Research Highlights: CHEST 2022 - 6 days

Mashup Score:3

Jean Elwing, MD, of the University of Cincinnati College of Medicine provides an overview of the latest clinical research about PAH presented at CHEST...

Mashup Score:3

CheckRare

What Is Mastocytosis? - 5 days

Mashup Score:3

Dr. Mariana C. Castells, Professor of Medicine at Harvard Medical School, gives an overview of...

Dr. Allen Davidoff, CEO of XORTX Therapeutics, discusses two phase 3 studies set to launch in the next two years evaluating oxypurinol in patients...

  • 1638617131586560020 Profile photo of Madelyn

    Allen Davidoff, PhD, CEO of XORTX Therapeutics, discusses two phase 3 studies set to launch in the next two years evaluating oxypurinol in patients with autosomal dominant polycystic kidney disease #ADPKD @XORTXinc #checkrare #rarediseases #XORTX https://t.co/WcCkqgoQKG - view on twitter

Drs Goker-Alpan and Jodele discuss current trends in gene therapy for lysosomal storage...

Dr. Allen Davidoff, CEO of XORTX Therapeutics, gives an overview of autosomal dominant polycystic kidney disease...

Mashup Score:2

CheckRare

GH Deficiency Research Highlights - 5 days

Mashup Score:2

Paul Saenger, MD MACE, Professor of Pediatrics Emeritus at Albert Einstein College of Medicine, provides an overview of the latest clinical research presented at...